Efficacy of rituximab in refractory and relapsing myositis with anti-JO1 antibodies: a report of two cases.
Frikha
Faten
F
Rigolet
Aude
A
Behin
Anthony
A
Fautrel
Bruno
B
Herson
Serge
S
Benveniste
Olivier
O
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies / Q000097:blood*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D005260:Female; D006643:Histidine-tRNA Ligase / Q000276:immunology*; D006801:Humans; D008875:Middle Aged; D009220:Myositis / Q000188:drug therapy*; D000069283:Rituximab; D016896:Treatment Outcome; D055815:Young Adult
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D000069283:Rituximab; D006643:Histidine-tRNA Ligase